-
Aug 18, 2025ADC Drug Development | Translational PK/PD Framework in Preclinical NHP StudiesPrisys Biotech provides translational PK/PD solutions for ADC development, leveraging NHP models, advanced bioanalysis, and quantitative modeling to optimize safety and efficacy... -
Aug 13, 2025NHP Pain Models For Translational Drug Discovery | Prisys BiotechPrisys Biotech offers advanced non-human primate (NHP) pain models with AI-driven behavior analysis, imaging, and neurophysiology to support translational drug discovery and eva... -
Jan 15, 20262025 Recap: How Prisys Is Redefining Translational Reliability in NHP ResearchDiscover how Prisys redefines translational reliability in non-human primate (NHP) studies through MRI-guided CNS delivery, AI-driven behavioral analytics, and audit-ready globa... -
Sep 29, 2025NHP-Based Pharmacology And Pharmacodynamic Services | Prisys BiotechPrisys Biotech offers cutting-edge non-human primate (NHP) pharmacology and pharmacodynamic services. Our advanced disease models, translational platforms, and AAALAC-accredited... -
Aug 05, 2025Serum Vs. Plasma: Choosing The Optimal Matrix For Preclinical BioanalysisDiscover how to choose between serum and plasma for drug analysis in preclinical studies. Prisys Biotech explains the scientific and operational trade-offs critical to accurate,... -
Jul 31, 2025Preclinical Dosing Guidelines: IV & PO Volume, PH, And Osmolarity For Accurat...Ensure accuracy in preclinical PK studies with optimized IV and PO dosing volumes, pH, and osmolality across species. Learn how Prisys Biotech enhances drug delivery in NHP and ... -
Jul 30, 2025Top COPD Research Models & Respiratory Platform Excellence By PrisysNHP COPD animal models and integrated respiratory research platform—empowering drug discovery through non-human primate models and precise drug delivery systems. -
Jul 22, 2025NHP Acute Hemorrhage Model: A Crucial Tool For Accelerating Novel Hematology ...Explore how Prisys Biotech's non-human primate (NHP) acute hemorrhage model provides a high-fidelity platform for evaluating novel therapies like hemoglobin-based oxygen carrier... -
Jul 18, 2025Pruritus Research: Prisys Biotech’s IL-31-Induced NHP Model For Evaluating An...Prisys Biotech offers a translational NHP pruritus model induced by IL-31. Leveraging an advanced AI behavioral analysis system, we provide objective quantification of scratchin... -
Jul 10, 2025A Guide To Anti-Drug Antibody (ADA) AssessmentExplore ADA formation, risk factors, impact on PK/ADME, and advanced preclinical assessment strategies, including the TDAR assay offered by Prisys Biotech. -
Jul 08, 2025Respiratory Therapies: Prisys Biotech's Integrated NHP Platform For Preclinic...Explore Prisys Biotech's comprehensive preclinical platform for respiratory diseases. Discover advanced NHP models, precision pulmonary drug delivery, BALF analysis, and PFTs de... -
Jul 04, 2025NHP Pain Models: Accelerating Analgesic Drug Development At Prisys BiotechExplore Prisys Biotech's validated non-human primate (NHP) pain models for acute, chronic, and neuropathic pain. Our advanced assessment technologies, including AI-driven behavi...
